Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Goerner

Re: Goerner

in response to by
posted on Dec 08, 2008 07:42AM

" We expect Crossflo to have a profitable 2009 plan with more specifics released before year-end."

a. " We expect to release a 2009 revenue plan by calendar year-end"


Share
New Message
Please login to post a reply